Parkinson’s Disease • • • • • • Case presentation Definitions Disease features Pathology Epidemiology Treatments George • 58 y.o. successful architect in large firm • 5/2010 –new onset tremor in right hand • handwriting has becoming smaller, less legible • 10/2010- neurologic examination • right hand tremor at rest, can control, but returns when distracted • slowed movements on right • muscle rigidity R > L George • Reports ↑ problems since late 2009 • • • • • • • lost client due to failure to pick up errors taking much more time to complete routine tasks referrals have dropped off substantially partner in firm suggesting he go on disability fatigued – leaving work early, going to bed before 9PM forgetting to pay bills at home yard work taking more time due to slowed movement PARKINSONISM (‘pill-rolling’) (slowed movement) (‘lead-pipe’ or ‘cog-wheel’) Clinical Features: Secondary motor symptoms • • • • Freezing Micrographia Masked faces Unwanted accelerations • Rapid stammering speech • Festinating gait • Stooped posture • Dystonia • Impaired motor dexterity/ coordination • Poverty of movement (decreased arm swing) • Akathisia • Speech problems • Hypophonia • Slurred • aprosody • Difficulty swallowing • Drooling Clinical Features: Non-motor symptoms Early • • • • • loss of sense of smell constipation REM behavior disorder mood disorders orthostatic hypotension Later • sleep disturbances • incontinence • sexual problems • excessive saliva • weight loss or gain • fatigue • Cognitive impairment • memory difficulties, slowed thinking, confusion, dementia • Psychiatric • Depression, anxiety Parkinsonian Syndromes • Idiopathic • Parkinson’s Disease • Symptomatic • Infectious (‘Awakenings’) • Toxic (Manganese, CO, MPTP) • Drug-induced (neuroleptics) • Post-traumatic (boxers) PD Motor Difficulties off-meds NBC Today Show Interview (1991) After Emergence of Post-traumatic Parkinsonism Basal Ganglia PD reflects Dopamine Insufficiency Lewy body Deposition of a-synuclein EPIDEMIOLOGY Parkinson’s Disease • Prevalence ~ 1,000,000 • Annual incidence of about 50,000 – 60,000 • Net prevalence increase of 15,000 patients annually • Average age of onset: 50 – 65 years old • 85% of patients over age 65 • Rare juvenile onset EPIDEMIOLOGY Parkinson’s Disease • Peak age at onset = 60 • 2% lifetime risk, 4% if affected relative • 850K in US • M:F = 3:2 • Highest rate in Hispanics, lowest in African Americans • Can live 20+ yrs with treatment Incidence by Period Olmstead Co., MN GENETIC FACTORS IN PD • Twin Studies • Similar MZ – DZ concordance in 193 twin pairs • In 16 twin pairs with early PD (< age 50), concordance was 4/4 MZ pairs & 2/12 DZ pairs, suggesting strong genetic contribution to early onset cases • Family Studies • Southern Italian family • ~ 10% have autosomal-dominant, autopsy-proven PD • Single base substitution on chromosome 4 at the gene that codes for alpha-synuclein protein. • High levels of alpha-synuclein aggregates found in Lewy bodies ENVIRONMENTAL RISK FACTORS • Case-control studies show increased risk of PD with exposure to: • Herbicides, Pesticides • Living in a rural environment • Consumption of well water • Proximity to industrial plants or quarries • Smoking associated with lower risk MPTP Model of PD • Parkinsonism seen in drug addicts exposed to synthetic heroin (MPTP) (cf ‘Awakening the Frozen Addicts’, 1993 BBC special on Youtube) • Progressed over several weeks and improved modestly with dopamine replacement therapy • No other neuronal involvement (‘pure parkinsonism’) • MPTP in primates induces parkinsonism and selective degeneration of nigro-striatal DA neurons • Chemical resemblance to some herbicides and pesticides suggests possible toxic etiology of PD via oxidative stress/other mechanisms PARKINSON’S DISEASE Non-Motor Features • • • • • Cognitive Dysfunction Depression Hallucinations (late) Autonomic dysfunction Personality change • restricted vs. compulsive behavior PARKINSON’S DISEASE Associated Features • • • • • Nigro-Striatal Pathway Meso-limbic & Meso-cortical Pathways Hypomimia (masked facies) • Dementia Shuffling or festinating gait • Depression (stooped posture, • Personality imbalance, short steps) Postural instability (easily Extra-CNS Structures pulled off balance) • Dermatitis Hypophonia (soft voice) • Constipation Dystonia (painful muscle • Sensory deficits contractions) Neuropsychological Profile in Early PD (Elgh et al., 2009) • Community-based (geographically-based referral center) • Only included patients who met PD criteria one year after initial baseline exam • Comprehensive neuropsych exam within 1-2 mos of prior to initiation of medications • Compared performances to age & gender matched controls (controls better educated) Adjusted for age, gender, education and psychomotor speed Symptomatic Treatment for PD • Replacement (Levodopa/Carbidopa) – • provide exogenous DA • most effective in relieving symptoms • use is typically delayed • may hasten emergence of diurnal fluctuations (‘off-on’, ‘wearing off’ periods) and dyskinesias • typically not prescribed until gait/postural problems arise or job is threatened • visual hallucinations, vivid dreams or nightmares occur in 20% of older patients ∙ changes the brain firing pattern but does not slow the progression of the neurodegeneration ∙ associated with reduction of sxs, so may enable reduction of medication ∙ can lead to a significant improvement in dyskinesias ∙ does not improve cognitive symptoms in PD and indeed may worsen them, so it is not generally used if there are signs of dementia. George’s Results WAIS-III WMS-III CVLT SS SS Similarities 15 Rey – Figure Copy 1 Block Design 10 Trail Making A 5 Letter-Num Seq. 13 Trail Making B 7 Digit Symbol 6 Phonemic Fluency 3 Imm. Memory 10 Category Fluency 12 Delayed Memory 9 Grooved Pegboard 4 Initial Learning 7 WCST Errors 3 Long Delay Free Recall 16 Categories 5 Impressions/Recommendations • Clinically significant weaknesses in processing speed and executive function • Consistent with impairments in multiple domains in earlyonset PD • Sufficient to explain his work and ADL deficits • Recommendations • Eligible for disability under current policy • Cognitive rehab. focused on executive dysfunction • Part-time consulting to exploit his wealth of knowledge George’s Results WAIS-III WMS-III CVLT Base line Base line 3 yrs 3 yrs Similarities 15 14 Rey – Figure Copy 1 n/a Block Design 10 5 Trail Making A 5 3 Letter-Num Seq. 13 7 Trail Making B 7 2 Digit Symbol 6 4 Phonemic Fluency 3 2 Imm. Memory 10 9 Category Fluency 12 6 Delayed Memory 9 5 Grooved Pegboard 4 3 Initial Learning 7 5 WCST Errors 3 1 Long Delay Free Recall 16 9 Categories 5 1